ResearcherHarvard UniversityActive in the last 2 years

David Lagares

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7317-8796; OpenAlex author ID A5067714754. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 21

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

Mechanosensing-inspired targeted nanosystem rewires heterogenous cancer-associated fibroblasts via CHIP activation in pancreatic ductal adenocarcinoma Co-author DOI 10.21203/rs.3.rs-6606556/v1 ↗
Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer. Last author DOI 10.1038/s41556-025-01697-8 ↗
Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-20-3892 ↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Miles Aaron Miller · 1 shared paper, 2026 · strength 0.29
- Paper Mechanosensing-inspired targeted nanosystem rewires heterogenous cancer-associated fibroblasts via CHIP activation in p… DOI 10.21203/rs.3.rs-6606556/v1 ↗
Ahmed M. R. H. Mostafa · 1 shared paper, 2026 · strength 0.29
- Paper Mechanosensing-inspired targeted nanosystem rewires heterogenous cancer-associated fibroblasts via CHIP activation in p… DOI 10.21203/rs.3.rs-6606556/v1 ↗
Praneeth Reddy Kuninty · 1 shared paper, 2026 · strength 0.29
- Paper Mechanosensing-inspired targeted nanosystem rewires heterogenous cancer-associated fibroblasts via CHIP activation in p… DOI 10.21203/rs.3.rs-6606556/v1 ↗
Jai Prakash · 1 shared paper, 2026 · strength 0.29
- Paper Mechanosensing-inspired targeted nanosystem rewires heterogenous cancer-associated fibroblasts via CHIP activation in p… DOI 10.21203/rs.3.rs-6606556/v1 ↗
David Tsai Ting · 1 shared paper, 2025 · strength 0.17
- Paper Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer. DOI 10.1038/s41556-025-01697-8 ↗
Taslim Ahmed Al-Hilal · 1 shared paper, 2025 · strength 0.17
- Paper Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer. DOI 10.1038/s41556-025-01697-8 ↗
Ellen Puré · 1 shared paper, 2025 · strength 0.17
- Paper Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer. DOI 10.1038/s41556-025-01697-8 ↗
Matteo Ligorio · 1 shared paper, 2025 · strength 0.17
- Paper Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer. DOI 10.1038/s41556-025-01697-8 ↗
Raghu Kalluri · 1 shared paper, 2025 · strength 0.17
- Paper Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer. DOI 10.1038/s41556-025-01697-8 ↗
Michael James Gough · 1 shared paper, 2021 · strength 0.09
- Paper Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancre… DOI 10.1158/0008-5472.can-20-3892 ↗
Martin D. McCarter · 1 shared paper, 2021 · strength 0.09
- Paper Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancre… DOI 10.1158/0008-5472.can-20-3892 ↗
Karyn A. Goodman · 1 shared paper, 2021 · strength 0.09
- Paper Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancre… DOI 10.1158/0008-5472.can-20-3892 ↗
Sara Zakem · 1 shared paper, 2021 · strength 0.09
- Paper Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancre… DOI 10.1158/0008-5472.can-20-3892 ↗
Miles Piper · 1 shared paper, 2021 · strength 0.09
- Paper Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancre… DOI 10.1158/0008-5472.can-20-3892 ↗
Ayman J. Oweida · 1 shared paper, 2021 · strength 0.09
- Paper Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancre… DOI 10.1158/0008-5472.can-20-3892 ↗
Sana D. Karam · 1 shared paper, 2021 · strength 0.09
- Paper Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancre… DOI 10.1158/0008-5472.can-20-3892 ↗
Adam Christopher Mueller · 1 shared paper, 2021 · strength 0.09
- Paper Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancre… DOI 10.1158/0008-5472.can-20-3892 ↗
Marco Del Chiaro · 1 shared paper, 2021 · strength 0.09
- Paper Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancre… DOI 10.1158/0008-5472.can-20-3892 ↗
Richard David Schulick · 1 shared paper, 2021 · strength 0.09
- Paper Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancre… DOI 10.1158/0008-5472.can-20-3892 ↗
Kirk Charles Hansen · 1 shared paper, 2021 · strength 0.09
- Paper Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancre… DOI 10.1158/0008-5472.can-20-3892 ↗
Wells A. Messersmith · 1 shared paper, 2021 · strength 0.09
- Paper Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancre… DOI 10.1158/0008-5472.can-20-3892 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.